Evidence map›Paper›PMID 41798749›Full record

ArticleFrontiers in cellular and infection microbiology2026

Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant

Defeng Liu, Kexin Zhang, Di Li, Qingqing Du, Yan Li, Jing Wang, Weiwei Jiang, Yan Qian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Defeng LiuDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Kexin ZhangImmunology Research Center, Medical Research Institute, Southwest University, Chongqing, China.
Di LiDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qingqing DuDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yan LiDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jing WangDepartment of Microbiology, College of Basic Medical Sciences, Army Medical University, Key Laboratory of Microbial Engineering Under the Educational Committee in Chongqing, Chongqing, China.
Weiwei JiangDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yan QianDepartment of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The growing global threat of multidrug-resistant Methods: AbpL was isolated from sewage samples and characterized in terms of its morphology, growth characteristics, stability, and genome. Comparative genomic classification analysis was also conducted on it. Results: AbpL is classified as a member of the genus Discussion: Owing to its strong lytic activity, environmental stability, and robust

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacteriophagesGenome, ViralPhage TherapyAnimalsAnti-Bacterial AgentsBacterial LoadBiofilmsCytokinesDisease Models, AnimalDrug Resistance, Multiple, BacterialHumansMiceSepsisSewageAnti-Bacterial AgentsCytokinesSewageAcinetobacter baumanniibacteriophage AbpLmultidrug-resistant infectionsphage therapyterminal redundancy

Identifiers

PMID41798749
PMCPMC12960631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.